Clinical Trial Update: A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children [Phase 3]

View source ↗

Summary

Phase 3 clinical study evaluating QLM3004 to delay myopia progression in children is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• QLM3004

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Myopia | Phase 3 | Status: RECRUITING